First Affiliated Hospital of Zhejiang University Schlool of Medicine
First Affiliated Hospital of Zhejiang University Schlool of Medicine
Hangzhou, Zhejiang, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2026-06-03 | NCT06770452 | |
| HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation | Borderline Resectable Pancreatic Adenocarcinoma | Recruiting | Phase 2 | 2026-02-13 | NCT07240766 | |
| IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer | Advanced Pancreatic Cancers | Recruiting | Phase 2 | 2025-09-23 | NCT06770439 | |
| Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-01-10 | NCT06572813 |